Company Filing History:
Years Active: 1985
Title: John R. Scott: Innovator in Allergy Measurement Technology
Introduction
John R. Scott is an accomplished inventor based in Mountain View, California, recognized for his significant contributions to the field of immunoassays. With a keen focus on allergen potency measurement, Scott's innovations pave the way for enhanced allergy diagnostics.
Latest Patents
Scott holds a notable patent for a "Fluorometric enzyme inhibition immunoassay for measuring potency of allergen extracts." This innovative method involves incubating a mixture of allergen extract and reference allergen specific IgE in a buffered solution on an insoluble support, where the reference allergen is adhered. The procedure utilizes enzyme-labeled anti-IgE antibodies that react with a substrate to yield a fluorescent product, which allows for precise measurements of fluoresce levels. By determining the percentage of inhibition of the allergen specific IgE from these fluorescence levels, Scott's patent provides a reliable mechanism for allergen potency assessment.
Career Highlights
Scott is currently associated with Axionics, Inc., where he continues to develop and refine technologies that impact the medical and allergy research fields. His work exemplifies the intersection of innovation and practical application in medical diagnostics.
Collaborations
While at Axionics, Inc., Scott has collaborated with talented colleagues, including Emanuel Calenoff and Yuh-Geng Tsay. These partnerships have undoubtedly contributed to the advancement of their research endeavors and the successful implementation of innovative solutions in the allergy field.
Conclusion
John R. Scott's pioneering work in immunoassay technology positions him as a valuable inventor in the allergy diagnostics arena. With his unique approach to measuring allergen potency, Scott is making strides that could lead to significant improvements in allergy treatment and management. His contributions illustrate the vital role of innovation in enhancing healthcare quality and patient outcomes.